SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-039083
Filing Date
2023-11-02
Accepted
2023-11-02 09:00:10
Documents
13
Period of Report
2023-10-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43027
2 ex99-1.htm EX-99.1 13519
  Complete submission text file 0001493152-23-039083.txt   231219

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE btax-20231024.xsd EX-101.SCH 3024
4 XBRL LABEL FILE btax-20231024_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE btax-20231024_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3072
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Biostax Corp. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 231370302
SIC: 2834 Pharmaceutical Preparations